// App-Quantinova.ai

: Amsacrine, Etoposide and Methylprednisolone As Part of the Therapy Intensification in Children with Acute Lymphoblastic Leukemia: A Retrospective Analysis in the Trial Coall 08-09

Researchers

Presenter

  • Gabriele Escherich

Principal Investigators

  • Katharina Wos

  • Franziska Schramm

  • Martin A. Horstmann

Medical Centers

  • Clinic of Pediatric Hematology and Oncology, University Medical Center Eppendorf, Eppendorf, Germany

  • Clinic of pediatric hematology and oncology, University medical center Hamburg Eppendorf, Hamburg, Germany

  • Department of Pediatric Hematology and Oncology, University Medical Center Eppendorf, Hamburg, Germany

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Methylprednisolone

  • Amsacrine

  • Etoposide

  • Etoposide phosphate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved